LGND

286.9650.01%
SL

Stephen Lawrence Sabba

Independent Director

Dr. Stephen Lawrence Sabba, M.D., has been a leading Bio/Pharma Analyst and Fund Manager for Knott Partners, L.P. since November 2006. He served as Board Observer at ILiAD Biotechnologies, LLC since March 2021 until March 2026. Dr. Sabba was a Partner and Director of Research of Kilkenny Capital Management, LLC. Prior to that, he served as Director of Research at Sturza's Medical Research (Sturza's Medical Research). He served as a Gastroenterologist and Internist in private practice at Phelps Memorial Hospital Association in North Tarrytown, New York. He has been an Independent Director of Ligand Pharmaceuticals Incorporated since August 4, 2008. He served as an Independent Director at Novelion Therapeutics Inc. since June 4, 2012 until January 16, 2020. He has been an Independent Director at QLT Inc., since June 4, 2012. He received his Medical Degree from the New York University School of Medicine and completed a residency in internal medicine and a fellowship in gastroenterology at the Veterans Administration Medical Center in New York City. Dr. Sabba earned a Bachelor of Science degree with honors at Cornell University.

Positions